These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24758626)

  • 21. Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.
    Golub JE; Cohn S; Saraceni V; Cavalcante SC; Pacheco AG; Moulton LH; Durovni B; Chaisson RE
    Clin Infect Dis; 2015 Feb; 60(4):639-45. PubMed ID: 25365974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality benefit of isoniazid preventive therapy in HIV-positive persons: a simulation study.
    Bachhuber MA; Gross R
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):1038-40. PubMed ID: 19723386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventive therapy against tuberculosis in people living with HIV.
    Wkly Epidemiol Rec; 1999 Nov; 74(46):385-98. PubMed ID: 10611855
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cost effectiveness analysis of isoniazid preventive therapy to the contacts of tuberculosis patients under Japanese settings].
    Yoshiyama T
    Kekkaku; 2000 Nov; 75(11):629-41. PubMed ID: 11140086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoniazid prophylaxis against tuberculosis in children.
    Zar HJ; Lombard C
    N Engl J Med; 2011 Oct; 365(16):1543; author reply 1543-4. PubMed ID: 22010924
    [No Abstract]   [Full Text] [Related]  

  • 26. BCG vaccination with antitubercular therapy.
    Amdekar YK
    Indian Pediatr; 1998 Oct; 35(10):1046-8. PubMed ID: 10216738
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.
    Chaisson RE; Barnes GL; Hackman J; Watkinson L; Kimbrough L; Metha S; Cavalcante S; Moore RD
    Am J Med; 2001 Jun; 110(8):610-5. PubMed ID: 11382368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoniazid to prevent first and recurrent episodes of TB.
    Ayles H; Muyoyeta M
    Trop Doct; 2006 Apr; 36(2):83-6. PubMed ID: 16611439
    [No Abstract]   [Full Text] [Related]  

  • 29. Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care.
    Tram KH; Mwangwa F; Atukunda M; Owaraganise A; Ayieko J; Plenty A; Kwariisima D; Clark TD; Petersen ML; Charlebois ED; Kamya MR; Chamie G; Havlir DV; Marquez C;
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):e115-e117. PubMed ID: 28885271
    [No Abstract]   [Full Text] [Related]  

  • 30. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia.
    Foster S; Godfrey-Faussett P; Porter J
    AIDS; 1997 Jun; 11(7):919-25. PubMed ID: 9189218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of latent tuberculosis infection.
    Parekh MJ; Schluger NW
    Ther Adv Respir Dis; 2013 Dec; 7(6):351-6. PubMed ID: 24056289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: Use of isoniazid chemoprophylaxis in renal transplantation.
    Ahmad R
    Nephrol Dial Transplant; 2010 Jun; 25(6):2038; author reply 2038. PubMed ID: 20305134
    [No Abstract]   [Full Text] [Related]  

  • 33. Tuberculosis preventive therapy for HIV-infected persons in less developed countries.
    Kritski AL
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S76-81. PubMed ID: 10688154
    [No Abstract]   [Full Text] [Related]  

  • 34. Monitored isoniazid prophylaxis for low-risk tuberculin reactors.
    Moulding T
    Ann Intern Med; 1998 Jun; 128(12 Pt 1):1048. PubMed ID: 9625675
    [No Abstract]   [Full Text] [Related]  

  • 35. Tuberculosis in patients with systemic lupus erythematosus.
    Mani MK
    J Assoc Physicians India; 1999 Jul; 47(7):747-8. PubMed ID: 10778610
    [No Abstract]   [Full Text] [Related]  

  • 36. For whom the bell tolls: isoniazid preventive therapy and tuberculosis drug resistance.
    Cobelens FG
    Sci Transl Med; 2013 Apr; 5(180):180fs12. PubMed ID: 23576813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Question from the clinician: tuberculosis prophylaxis.
    Wald E
    Pediatr Rev; 2003 Oct; 24(10):355. PubMed ID: 14523162
    [No Abstract]   [Full Text] [Related]  

  • 38. Protecting young healthcare trainees from tuberculosis: can we overcome apathy?
    Pai M; Christopher DJ
    Natl Med J India; 2011; 24(4):198-200. PubMed ID: 22208137
    [No Abstract]   [Full Text] [Related]  

  • 39. No effect of isoniazid prophylaxis for purified protein derivative-negative HIV-infected adults living in a country with endemic tuberculosis: results of a randomized trial.
    Fitzgerald DW; Severe P; Joseph P; Mellon LR; Noel E; Johnson WD; Pape JW
    J Acquir Immune Defic Syndr; 2001 Nov; 28(3):305-7. PubMed ID: 11694842
    [No Abstract]   [Full Text] [Related]  

  • 40. Isoniazid prophylaxis in end-stage renal disease.
    Bal AM
    Transpl Infect Dis; 2006 Dec; 8(4):242-3; author reply 243. PubMed ID: 17116141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.